Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEUROMYELITIS OPTICA SPECTRUM DISORDER: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | NEUROMYELITIS OPTICA SPECTRUM DISORDER |
Knowledge base pages for this entity
graph TD
NEUROMYELITIS_OPTICA_SPECTRUM_["NEUROMYELITIS OPTICA SPECTRUM DISORDER"]
Aquaporin_4_Immunoglobulin_G["Aquaporin-4 Immunoglobulin G"] -.biomarker for.-> NEUROMYELITIS_OPTICA_SPECTRUM_
AQP4_Ab["AQP4-Ab"] -.biomarker for.-> NEUROMYELITIS_OPTICA_SPECTRUM_
AQP4["AQP4"] -.biomarker for.-> NEUROMYELITIS_OPTICA_SPECTRUM_
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"involved_in"| NEUROMYELITIS_OPTICA_SPECTRUM_
DEMYELINATION["DEMYELINATION"] -->|"involved_in"| NEUROMYELITIS_OPTICA_SPECTRUM_
OPTIC_NERVE["OPTIC NERVE"] -->|"involved_in"| NEUROMYELITIS_OPTICA_SPECTRUM_
SPINAL_CORD["SPINAL CORD"] -->|"involved_in"| NEUROMYELITIS_OPTICA_SPECTRUM_| Target | Relation | Type | Str |
|---|---|---|---|
| Optic Neuritis | associated_with | disease | 0.90 |
| Transverse Myelitis | associated_with | disease | 0.90 |
| Demyelinating Disease | associated_with | disease | 0.90 |
| Optic Chiasm T2 Lesion | associated_with | phenotype | 0.88 |
| Longitudinal Extensive Transverse Myelitis | associated_with | phenotype | 0.87 |
| Area Postrema T2 Lesion | associated_with | phenotype | 0.85 |
| Hypothalamic T2 Lesion | associated_with | phenotype | 0.83 |
| Spinal Cord Atrophy | associated_with | phenotype | 0.82 |
| Multiple Sclerosis | associated_with | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Aquaporin-4 Immunoglobulin G | biomarker_for | biomarker | 0.95 |
| AQP4-Ab | biomarker_for | biomarker | 0.95 |
| AQP4 | biomarker_for | protein | 0.95 |
| AQP4-ANTIBODY | causes | protein | 0.95 |
| AQP4 | associated_with | protein | 0.95 |
| Aquaporin-4-Antibody | associated_with | biomarker | 0.95 |
| AQP4-IgG | biomarker_for | biomarker | 0.95 |
| AQP4 | associated_with | entity | 0.95 |
| NEUROINFLAMMATION | involved_in | entity | 0.95 |
| DEMYELINATION | involved_in | entity | 0.95 |
| AQP4 | biomarker_for | entity | 0.95 |
| OPTIC NERVE | involved_in | entity | 0.95 |
| SPINAL CORD | involved_in | entity | 0.95 |
| AQP4-IgG | causes | protein | 0.92 |
| Inebilizumab | treats | drug | 0.90 |
| Optic Neuritis | associated_with | phenotype | 0.90 |
| AQP4 immunoglobulin G | contributes_to | protein | 0.90 |
| complement activation | drives | pathway | 0.90 |
| B-cell-mediated immunity | mediates | pathway | 0.90 |
| central nervous system | involved_in | brain_region | 0.90 |
| IL6 | therapeutic_target | entity | 0.90 |
| CD19 | therapeutic_target | entity | 0.90 |
| COMPLEMENT | therapeutic_target | entity | 0.90 |
| AQP4-IGG | biomarker_for | entity | 0.90 |
| INEBILIZUMAB | treats | entity | 0.90 |
| RITUXIMAB | treats | entity | 0.90 |
| STEROIDS | treats | entity | 0.90 |
| PLASMA EXCHANGE | treats | entity | 0.90 |
| B CELL | involved_in | entity | 0.90 |
| LYMPHOCYTE | involved_in | entity | 0.90 |
| EOSINOPHIL | involved_in | entity | 0.90 |
| GRANULOCYTE | involved_in | entity | 0.90 |
| B Cell | contributes_to | cell_type | 0.90 |
| CD20+ B Cell Count | associated_with | biomarker | 0.85 |
| CD27+ B Cell Count | associated_with | biomarker | 0.85 |
| Satralizumab | treats | drug | 0.85 |
| Eculizumab | treats | drug | 0.85 |
| CD20 | associated_with | protein | 0.85 |
| CD27 | associated_with | protein | 0.85 |
| B cell depletion | suppresses | process | 0.85 |
| IL6 | contributes_to | gene | 0.85 |
| complement inhibitors | treats | drug | 0.85 |
| B-cell pathway inhibitors | treats | drug | 0.85 |
| sustained immunosuppression | treats | process | 0.85 |
| AQP4 | implicated_in | protein | 0.85 |
| CD20 | biomarker_for | entity | 0.85 |
| CD27 | biomarker_for | entity | 0.85 |
| PLASMABLAST | biomarker_for | entity | 0.85 |
| Plasmablast | associated_with | cell_type | 0.82 |
| Plasma Cell | associated_with | cell_type | 0.82 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity